Arthur D Little forms drug delivery deal with Vectura
This article was originally published in Clinica
Executive Summary
Arthur D Little (ADL) is to merge its inhalation drug delivery technology, Aspirair, into Vectura in a deal worth around $5 million. ADL's European technology arm will buy a stake in European drug delivery company Vectura, as well as taking a seat on the board.